VIR-5525

· Vir Biotechnology, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VIR-5525, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]

See pricing